Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amarin Stock Is Jumping Today

TheMotleyFool

0 0

Shares of Amarin (NASDAQ: AMRN) jumped by as much as 11.7% in pre-market trading Monday morning. What's driving this sizable move higher ahead of the opening bell?

On Friday, Amarin announced that the Food and Drug Administration had approved Vascepa as an add-on to statin therapy in patients with elevated triglyceride levels who either have established cardiovascular disease or diabetes mellitus with two additional risk factors for cardiovascular disease.

Image Source: Getty Images.

Source Fool.com

Like: 0

AMRN

Share